Boston Scientific To Release Broad Range Of Clinical Trial Data On The Performance Of TAXUS(R) Coronary Stent Systems At TCT 2008 Boston Scientific Corporation (NYSE: BSX) announced the schedule of the Company's major events and press announcements at the Cardiovascular Research Foundation's (CRF) twentieth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, which runs from October 12 to 17 in Washington, D.C.
Source: www.medicalnewstoday.comFDA Continues Review Of Takeda's New Drug Application For Alogliptin (SYR-322), A DPP-4 Agent For Type 2 Diabetes Takeda Pharmaceutical Company Limited ("Takeda") announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the
Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.
Source: www.medicalnewstoday.com
# posted by Network @ 4:00 AM
